Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-12-07 Purchase | 2023-12-08 08:00 am | SAB Biotherapeutics Inc. | SABS | Sullivan Eddie Joe Chief Executive Officer | 1,740 | $0.88 | $1,531 | 5,232,304 (Direct) | View |
| 2023-11-30 Purchase | 2023-11-30 5:00 pm | SAB Biotherapeutics Inc. | SABS | King Michael CHIEF FINANCIAL OFFICER | 5,000 | $0.9 | $4,500 | 5,000 (Direct) | View |
| 2023-11-29 Purchase | 2023-11-30 08:00 am | SAB Biotherapeutics Inc. | SABS | Reich Samuel J Executive Chairman | 11,000 | $0.8947 | $9,842 | 766,699 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-01 Option Award | 2024-11-05 4:41 pm | N/A 2034-11-01 | SAB Biotherapeutics Inc. | SABS | Ellias Helen K. Director | 55,000 | $0 | 55,000 (Direct) | View |
| 2024-08-12 Option Award | 2024-08-13 5:00 pm | N/A 2034-08-12 | SAB Biotherapeutics Inc. | SABS | To Lucy See Remarks | 125,000 | $0 | 125,000 (Direct) | View |
| 2024-07-15 Option Award | 2024-07-17 4:30 pm | N/A 2034-07-15 | SAB Biotherapeutics Inc. | SABS | Spragens Jeffrey G Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2024-07-15 Option Award | 2024-07-17 4:30 pm | N/A 2034-07-15 | SAB Biotherapeutics Inc. | SABS | Polvino William James Director | 33,958 | $0 | 33,958 (Direct) | View |
| 2024-07-15 Option Award | 2024-07-17 4:30 pm | N/A 2034-07-15 | SAB Biotherapeutics Inc. | SABS | SKYLER JAY S Director | 55,000 | $0 | 55,000 (Direct) | View |
| 2024-07-15 Option Award | 2024-07-17 4:30 pm | N/A 2034-07-15 | SAB Biotherapeutics Inc. | SABS | Sullivan Eddie Joe PRESIDENT | 50,975 | $0 | 50,975 (Direct) | View |
| 2024-07-15 Option Award | 2024-07-17 4:30 pm | N/A 2034-07-15 | SAB Biotherapeutics Inc. | SABS | Lucera Erick Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2024-07-15 Option Award | 2024-07-17 4:30 pm | N/A 2034-07-15 | SAB Biotherapeutics Inc. | SABS | HAMILTON CHRISTINE E Director | 76,790 | $0 | 76,790 (Direct) | View |
| 2024-07-15 Option Award | 2024-07-17 4:30 pm | N/A 2034-07-15 | SAB Biotherapeutics Inc. | SABS | Link David Charles Director | 29,305 | $0 | 29,305 (Direct) | View |
| 2024-07-15 Option Award | 2024-07-17 4:30 pm | N/A 2034-07-15 | SAB Biotherapeutics Inc. | SABS | Reich Samuel J CEO & EXECUTIVE CHAIRMAN | 35,700 | $0 | 35,700 (Direct) | View |
| 2024-07-15 Option Award | 2024-07-17 4:30 pm | N/A 2034-07-15 | SAB Biotherapeutics Inc. | SABS | Giberson Scott Director | 20,000 | $0 | 20,000 (Direct) | View |
Ownership | 2024-06-24 5:00 pm | N/A 2033-11-06 | SAB Biotherapeutics Inc. | SABS | Conley Mark William See Remarks | 0 | $0 | 25,000 (Direct) | View |
| 2024-02-21 Option Award | 2024-02-23 5:00 pm | N/A 2034-02-21 | SAB Biotherapeutics Inc. | SABS | Kropotova Alexandra CHIEF MEDICAL OFFICER | 140,000 | $0 | 140,000 (Direct) | View |
| 2024-02-21 Option Award | 2024-02-23 4:55 pm | N/A 2034-02-21 | SAB Biotherapeutics Inc. | SABS | Sullivan Eddie Joe PRESIDENT | 190,000 | $0 | 190,000 (Direct) | View |
| 2024-02-21 Option Award | 2024-02-23 4:50 pm | N/A 2034-02-21 | SAB Biotherapeutics Inc. | SABS | Bausch Christoph Lawrence CHIEF OPERATING OFFICER | 140,000 | $0 | 140,000 (Direct) | View |
| 2024-02-21 Option Award | 2024-02-23 4:45 pm | N/A 2034-02-21 | SAB Biotherapeutics Inc. | SABS | King Michael CHIEF FINANCIAL OFFICER | 115,000 | $0 | 115,000 (Direct) | View |
| 2024-02-21 Option Award | 2024-02-23 4:40 pm | N/A 2034-02-21 | SAB Biotherapeutics Inc. | SABS | Reich Samuel J CEO & EXECUTIVE CHAIRMAN | 434,000 | $0 | 434,000 (Direct) | View |
| 2023-11-24 Exercise | 2023-11-28 4:05 pm | N/A N/A | SAB Biotherapeutics Inc. | SABS | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John Director | 59,649 | $1000 | 4,612,951 (Direct) | View |
| 2023-11-24 Exercise | 2023-11-28 4:05 pm | N/A N/A | SAB Biotherapeutics Inc. | SABS | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John Director | 4,584,571 | $0 | 4,612,951 (Direct) | View |
| 2023-11-24 Exercise | 2023-11-28 4:05 pm | N/A N/A | SAB Biotherapeutics Inc. | SABS | Moin Andrew Director | 59,649 | $1000 | 4,612,951 (Indirect) | View |
| 2023-11-24 Exercise | 2023-11-28 4:05 pm | N/A N/A | SAB Biotherapeutics Inc. | SABS | Moin Andrew Director | 4,584,571 | $0 | 4,612,951 (Indirect) | View |
| 2023-11-24 Exercise | 2023-11-28 4:05 pm | N/A N/A | SAB Biotherapeutics Inc. | SABS | Ellias Helen K. Director | 1,800 | $1000 | 2,857,142 (Indirect) | View |
| 2023-11-24 Exercise | 2023-11-28 4:05 pm | N/A N/A | SAB Biotherapeutics Inc. | SABS | Ellias Helen K. Director | 2,857,142 | $0 | 2,857,142 (Indirect) | View |
Ownership | 2023-11-22 4:30 pm | N/A N/A | SAB Biotherapeutics Inc. | SABS | Ellias Helen K. Director | 0 | $0 | 2,861,342 (Indirect) | View |
| 2023-11-13 Option Award(A) | 2023-11-15 9:10 pm | N/A N/A | SAB Biotherapeutics Inc. | SABS | Moin Andrew Director | 13,269 | $1000 | 31,269 (Indirect) | View |
| 2023-11-13 Option Award(A) | 2023-11-15 4:30 pm | N/A N/A | SAB Biotherapeutics Inc. | SABS | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John Director | 13,269 | $1000 | 31,269 (Direct) | View |
| 2023-11-13 Option Award | 2023-11-14 7:00 pm | N/A N/A | SAB Biotherapeutics Inc. | SABS | Moin Andrew Director | 13,269 | $1000 | 99,499 (Indirect) | View |
| 2023-11-13 Exercise | 2023-11-14 7:00 pm | N/A N/A | SAB Biotherapeutics Inc. | SABS | Moin Andrew Director | 13,269 | $0 | 99,499 (Indirect) | View |
| 2023-11-10 Option Award | 2023-11-14 7:00 pm | N/A N/A | SAB Biotherapeutics Inc. | SABS | Moin Andrew Director | 44,230 | $0 | 99,499 (Indirect) | View |
| 2023-11-13 Option Award | 2023-11-14 4:08 pm | N/A N/A | SAB Biotherapeutics Inc. | SABS | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John Director | 13,269 | $1000 | 117,499 (Direct) | View |
| 2023-11-13 Exercise | 2023-11-14 4:08 pm | N/A N/A | SAB Biotherapeutics Inc. | SABS | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John Director | 13,269 | $0 | 117,499 (Direct) | View |
| 2023-11-10 Option Award | 2023-11-14 4:08 pm | N/A N/A | SAB Biotherapeutics Inc. | SABS | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John Director | 44,230 | $0 | 117,499 (Direct) | View |
| 2023-10-30 Option Award | 2023-11-03 4:50 pm | N/A 2033-10-30 | SAB Biotherapeutics Inc. | SABS | King Michael CHIEF FINANCIAL OFFICER | 850,000 | $0 | 850,000 (Direct) | View |
| 2023-10-23 Option Award | 2023-10-24 5:33 pm | N/A N/A | SAB Biotherapeutics Inc. | SABS | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John Director | 16,269 | $1000 | 18,000 (Direct) | View |
| 2023-10-23 Exercise | 2023-10-24 5:33 pm | N/A N/A | SAB Biotherapeutics Inc. | SABS | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John Director | 16,269 | $0 | 18,000 (Direct) | View |
| 2023-10-23 Option Award | 2023-10-24 5:30 pm | N/A N/A | SAB Biotherapeutics Inc. | SABS | Moin Andrew Director | 16,269 | $1000 | 18,000 (Indirect) | View |
| 2023-10-23 Exercise | 2023-10-24 5:30 pm | N/A N/A | SAB Biotherapeutics Inc. | SABS | Moin Andrew Director | 16,269 | $0 | 18,000 (Indirect) | View |
Ownership | 2023-10-10 4:24 pm | N/A N/A | SAB Biotherapeutics Inc. | SABS | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John Director | 0 | $0 | 2,805,366 (Direct) | View |
Ownership | 2023-10-10 4:05 pm | N/A N/A | SAB Biotherapeutics Inc. | SABS | Moin Andrew Director | 0 | $0 | 2,805,366 (Indirect) | View |
| 2023-04-03 Option Award | 2023-04-05 5:01 pm | N/A 2033-04-03 | SAB Biotherapeutics Inc. | SABS | Lucera Erick Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-16 4:30 pm | N/A N/A | SAB Biotherapeutics Inc. | SABS | Kropotova Alexandra Chief Medical Officer | 275,000 | $0 | 275,000 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-16 4:29 pm | N/A 2033-03-14 | SAB Biotherapeutics Inc. | SABS | Sullivan Eddie Joe Chief Executive Officer | 525,000 | $0 | 525,000 (Direct) | View |